Interlaminar stabilization for spinal stenosis in the Medicare population

Area of Science:

• Spine surgery outcomes
• Minimally invasive spinal procedures
• Geriatric orthopedic surgery

Background:

• Complex spinal fusions in Medicare beneficiaries (≥65) with lumbar spinal stenosis are increasing.
• These fusions are invasive, lengthy, and carry higher complication risks.
• Interlaminar stabilization (ILS) offers an alternative between decompression alone and fusion.

Purpose of the Study:

• To prospectively evaluate the efficacy of ILS in patients aged 65 and older.
• To compare ILS in older patients to traditional fusion in the same age group.
• To compare ILS in older patients to ILS in younger patients.

Main Methods:

• A prospective, multicentered, randomized controlled trial.
• Compared decompression with ILS versus decompression with fusion in patients aged 65+.
• Also compared ILS in patients <65 versus ≥65.
• Patients had moderate lumbar spinal stenosis and failed conservative treatment.

Main Results:

• No significant differences in Composite Clinical Success (CCS) at 24 and 60 months between ILS (≥65) and fusion (≥65) groups.
• No significant differences in CCS between ILS (<65) and ILS (≥65) groups.
• ILS patients (≥65) had significantly shorter surgeries, less blood loss, and shorter hospital stays than fusion patients (≥65).

Conclusions:

• Interlaminar stabilization (ILS) is clinically effective for Medicare patients aged 65+ with lumbar spinal stenosis.
• ILS provides comparable outcomes to fusion in older adults.
• ILS offers significant benefits in reduced surgical invasiveness for the older population.